Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.830
+0.060 (3.39%)
At close: Feb 6, 2026, 4:00 PM EST
1.821
-0.009 (-0.49%)
After-hours: Feb 6, 2026, 7:59 PM EST
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $4.37 million as of February 6, 2026. Its market cap has decreased by -7.70% in one year.
Market Cap
4.37M
Enterprise Value
-296.61K
1-Year Change
-7.70%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $4.37M, a decrease of -92.40%. That is a compound annual growth rate of -43.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 4.37M | 60.11% |
| Dec 31, 2025 | 2.73M | -0.99% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silexion Therapeutics | 5.03M |
| Decoy Therapeutics | 4.98M |
| Aprea Therapeutics | 4.83M |
| Xenetic Biosciences | 4.77M |
| GeoVax Labs | 4.59M |
| Abpro Holdings | 4.10M |
| Cyclerion Therapeutics | 4.09M |
| Silo Pharma | 4.08M |